Genetics Quiz: Test Performance In Screening

What this quiz covers

This quiz focuses on Test Performance In Screening, giving you a quick way to practice the rules, question types, and explanations that matter most for Genetics.

How to use this quiz

Try each quiz question before looking at the correct answer. Use the explanations to review missed ideas, then come back to similar questions until the pattern feels familiar.

Question 1

1. 25
2. 475
3. 950 (correct answer)
4. 8550

Explanation: This is a multi-step problem. First, determine the number of people without the condition: 10,000 (total) - 500 (with condition) = 9,500. Specificity is the proportion of disease-free individuals who test negative. A specificity of 90% means the false positive rate is 100% - 90% = 10%. False positives occur in the disease-free group. Therefore, the number of false positives is 10% of 9,500, which is 0.10 * 9,500 = 950.

Question 2

1. High specificity, to avoid parental anxiety from false positives.
2. High sensitivity, to ensure no affected newborns are missed. (correct answer)
3. High positive predictive value, to ensure most positive results are true.
4. Low cost, to allow for widespread population screening.

Explanation: In a screening scenario for a serious but treatable disease, the primary goal is to identify all affected individuals. Therefore, high sensitivity (a low false-negative rate) is the most critical characteristic. The consequence of a false negative (missing a case) is severe and irreversible damage. While high specificity is also desirable to reduce false positives, it is secondary to ensuring that all true cases are caught for treatment.

Question 3

1. It will increase proportionally with the prevalence.
2. It will decrease because of more true positives.
3. It cannot be determined without knowing the new specificity.
4. It will remain unchanged. (correct answer)

Explanation: When you encounter questions about diagnostic test performance, remember that sensitivity and specificity are intrinsic properties of the test itself—they don't change based on the population being tested. These measures reflect how well the test performs under controlled conditions. Sensitivity measures the test's ability to correctly identify people who actually have the disease (true positive rate), while specificity measures its ability to correctly identify people who don't have the disease (true negative rate). These properties depend on the test's biological or technical characteristics, not on how common the disease is in different populations. The correct answer is D because sensitivity remains unchanged regardless of disease prevalence. A test that correctly identifies 90% of affected individuals will continue to do so whether the disease affects 1 in 1,000 people or 5 in 1,000 people. Choice A incorrectly suggests sensitivity varies with prevalence—this confuses sensitivity with positive predictive value, which does change with prevalence. Choice B misunderstands the relationship between true positives and sensitivity; while higher prevalence means more true positives in absolute numbers, the proportion of diseased individuals correctly identified stays constant. Choice C incorrectly implies that specificity affects sensitivity or that you need additional information—sensitivity and specificity are independent measures. Remember this key distinction: sensitivity and specificity are properties of the test itself, while positive and negative predictive values are what change when you apply that same test to populations with different disease prevalence rates.

Question 4

1. 90.0%
2. 91.8%
3. 98.0% (correct answer)
4. 99.4%

Explanation: Specificity is the ability of a test to correctly identify those without the disease. It is calculated as True Negatives / (True Negatives + False Positives). In this cohort, there are 4,900 unaffected pregnancies. The test correctly identified 4,802 of them as negative (True Negatives). The number of False Positives is the number of unaffected pregnancies that tested positive, which is 4,900 - 4,802 = 98. Therefore, specificity = 4,802 / (4,802 + 98) = 4,802 / 4,900 = 0.98 or 98.0%.

Question 5

1. The total number of individuals who truly have the condition. (correct answer)
2. The total number of individuals who received a positive test result.
3. The total number of individuals correctly classified by the test.
4. The total number of individuals participating in the study.

Explanation: When evaluating diagnostic tests in genetics, understanding sensitivity helps you assess how well a test identifies individuals who actually have a genetic condition. Sensitivity measures the proportion of true cases that the test correctly identifies as positive. The sensitivity formula is: $\text{Sensitivity} = \frac{\text{TP}}{\text{TP + FN}}$ The denominator (TP + FN) represents all individuals who truly have the condition being tested for. Think about it logically: true positives are people with the condition who test positive, while false negatives are people with the condition who test negative. Together, these two groups make up everyone who actually has the condition, regardless of their test results. Looking at the incorrect options: Option B describes those who tested positive (TP + FP), which would be the denominator for positive predictive value, not sensitivity. Option C refers to all correctly classified individuals (TP + TN), which relates to overall test accuracy. Option D simply describes the entire study population, which includes all four categories of test outcomes. The key insight is that sensitivity specifically measures how well a test performs among those who have the condition. It asks: "Of all the people who actually have this genetic condition, what percentage does our test successfully identify?" This makes sensitivity particularly important in genetics when you need to ensure that individuals with serious hereditary conditions aren't missed. Remember: sensitivity focuses on the condition-positive population, while specificity focuses on the condition-negative population. Keep these denominators straight by thinking about which group each metric is designed to evaluate.

Question 6

1. 160
2. 190
3. 18,810 (correct answer)
4. 19,000

Explanation: This requires multiple steps. First, calculate the number of individuals with and without the condition. With condition: 1% of 20,000 = 200. Without condition: 99% of 20,000 = 19,800. True negatives are found within the group without the condition. The number of true negatives is calculated by multiplying the number of disease-free individuals by the specificity. Number of True Negatives = 19,800 * 0.95 = 18,810.

Question 7

1. Test A, because its high sensitivity will confirm the initial finding.
2. Test B, because its high specificity is needed to rule out false positives. (correct answer)
3. Either test is equally appropriate as they have complementary performance.
4. Neither test, a third test with balanced sensitivity and specificity is required.

Explanation: The initial screening test was highly sensitive, meaning it was good at detecting potential cases but likely produced a number of false positives. The purpose of a confirmatory test is to rule out these false positives and confirm the diagnosis. This requires a test with high specificity, which is the ability to correctly identify individuals who do not have the disease. Test B, with its 99% specificity, is therefore the ideal choice.

Question 8

1. The tests from the two labs have identical sensitivity. (correct answer)
2. Lab A's test has a higher specificity than Lab B's test.
3. Lab B's test will produce more false positives than Lab A's test.
4. The prevalence of the disease was higher in the population tested by Lab A.

Explanation: When you encounter genetic test validation questions, focus on the precise definitions of sensitivity, specificity, and error rates. These terms have exact mathematical relationships that don't change between labs. Sensitivity measures a test's ability to correctly identify positive cases, calculated as: $\text{Sensitivity} = \frac{\text{True Positives}}{\text{True Positives + False Negatives}}$. The false negative rate is simply 100% minus sensitivity. If Lab A has 92% sensitivity, its false negative rate is 8%. Lab B directly reports an 8% false negative rate, meaning its sensitivity is also 92%. Therefore, both tests have identical sensitivity, making answer A correct. Answer B is wrong because we have no information about specificity, which relates to false positive rates and true negatives—completely separate from the sensitivity data given. Answer C is incorrect for the same reason; false positive rates depend on specificity, not sensitivity. We cannot determine anything about false positives from the provided information. Answer D is flawed because disease prevalence in the tested populations doesn't affect the intrinsic performance characteristics of the tests themselves. Sensitivity and specificity are properties of the test, not the population. Study tip: Remember that sensitivity = 100% - false negative rate, and specificity = 100% - false positive rate. These are fixed test characteristics. Don't confuse them with prevalence, which describes the population being tested. On genetics exams, always identify which test performance metric is actually being discussed before drawing conclusions.

Question 9

1. 81.8%
2. 90.0% (correct answer)
3. 95.0%
4. 97.3%

Explanation: Sensitivity is the proportion of individuals with the disease who test positive. It is calculated as True Positives / (True Positives + False Negatives). Here, the number of individuals with the disease is 200. The number of true positives (diseased individuals who test positive) is 180. The number of false negatives (diseased individuals who test negative) is 200 - 180 = 20. Thus, sensitivity = 180 / (180 + 20) = 180 / 200 = 0.90 or 90.0%.

Question 10

1. 2.5%
2. 90.0%
3. 97.5% (correct answer)
4. 99.75%

Explanation: Specificity is the proportion of disease-free individuals who test negative. The total number of disease-free individuals is 1,000. We are given that there are 25 false positives (FP). The number of true negatives (TN) is the total number of disease-free individuals minus the false positives: TN = 1,000 - 25 = 975. Specificity is calculated as TN / (TN + FP) = 975 / (975 + 25) = 975 / 1,000 = 0.975 or 97.5%.

Question 11

1. The test's specificity is 95%.
2. The test's sensitivity is 95%. (correct answer)
3. Among those who test negative, 5% actually have the disorder.
4. Among healthy individuals, 5% will test positive.

Explanation: The false negative rate (FNR) is the proportion of individuals with the disease who test negative (FN / (TP + FN)). Sensitivity is the proportion of individuals with the disease who test positive (TP / (TP + FN)). Since every individual with the disease either tests positive (TP) or negative (FN), the sum of these proportions must be 1. Therefore, Sensitivity = 1 - FNR. If the FNR is 5% (0.05), the sensitivity is 1 - 0.05 = 0.95, or 95%.

Question 12

1. High specificity, to avoid parental anxiety from false positives.
2. High sensitivity, to ensure no affected newborns are missed. (correct answer)
3. High positive predictive value, to ensure most positive results are true.
4. Low cost, to allow for widespread population screening.

Explanation: In a screening scenario for a serious but treatable disease, the primary goal is to identify all affected individuals. Therefore, high sensitivity (a low false-negative rate) is the most critical characteristic. The consequence of a false negative (missing a case) is severe and irreversible damage. While high specificity is also desirable to reduce false positives, it is secondary to ensuring that all true cases are caught for treatment.

Question 13

1. Test A, because its high sensitivity will confirm the initial finding.
2. Test B, because its high specificity is needed to rule out false positives. (correct answer)
3. Either test is equally appropriate as they have complementary performance.
4. Neither test, a third test with balanced sensitivity and specificity is required.

Explanation: The initial screening test was highly sensitive, meaning it was good at detecting potential cases but likely produced a number of false positives. The purpose of a confirmatory test is to rule out these false positives and confirm the diagnosis. This requires a test with high specificity, which is the ability to correctly identify individuals who do not have the disease. Test B, with its 99% specificity, is therefore the ideal choice.

Question 14

1. 81.8%
2. 90.0% (correct answer)
3. 95.0%
4. 97.3%

Explanation: Sensitivity is the proportion of individuals with the disease who test positive. It is calculated as True Positives / (True Positives + False Negatives). Here, the number of individuals with the disease is 200. The number of true positives (diseased individuals who test positive) is 180. The number of false negatives (diseased individuals who test negative) is 200 - 180 = 20. Thus, sensitivity = 180 / (180 + 20) = 180 / 200 = 0.90 or 90.0%.

Question 15

1. It will increase proportionally with the prevalence.
2. It will decrease because of more true positives.
3. It cannot be determined without knowing the new specificity.
4. It will remain unchanged. (correct answer)

Explanation: When you encounter questions about diagnostic test performance, remember that sensitivity and specificity are intrinsic properties of the test itself—they don't change based on the population being tested. These measures reflect how well the test performs under controlled conditions. Sensitivity measures the test's ability to correctly identify people who actually have the disease (true positive rate), while specificity measures its ability to correctly identify people who don't have the disease (true negative rate). These properties depend on the test's biological or technical characteristics, not on how common the disease is in different populations. The correct answer is D because sensitivity remains unchanged regardless of disease prevalence. A test that correctly identifies 90% of affected individuals will continue to do so whether the disease affects 1 in 1,000 people or 5 in 1,000 people. Choice A incorrectly suggests sensitivity varies with prevalence—this confuses sensitivity with positive predictive value, which does change with prevalence. Choice B misunderstands the relationship between true positives and sensitivity; while higher prevalence means more true positives in absolute numbers, the proportion of diseased individuals correctly identified stays constant. Choice C incorrectly implies that specificity affects sensitivity or that you need additional information—sensitivity and specificity are independent measures. Remember this key distinction: sensitivity and specificity are properties of the test itself, while positive and negative predictive values are what change when you apply that same test to populations with different disease prevalence rates.

Question 16

1. 35
2. 170
3. 200 (correct answer)
4. 255

Explanation: This requires working backwards. Sensitivity = TP / (TP + FN). A sensitivity of 85% means the false negative rate is 100% - 85% = 15%. The false negative rate is defined as FN / (Total with disease). We are given that FN = 30. So, 0.15 = 30 / (Total with disease). Rearranging the formula: Total with disease = 30 / 0.15 = 200. Thus, 200 individuals in the cohort had the disorder.

Question 17

1. 160
2. 190
3. 18,810 (correct answer)
4. 19,000

Explanation: This requires multiple steps. First, calculate the number of individuals with and without the condition. With condition: 1% of 20,000 = 200. Without condition: 99% of 20,000 = 19,800. True negatives are found within the group without the condition. The number of true negatives is calculated by multiplying the number of disease-free individuals by the specificity. Number of True Negatives = 19,800 * 0.95 = 18,810.

Question 18

1. The tests from the two labs have identical sensitivity. (correct answer)
2. Lab A's test has a higher specificity than Lab B's test.
3. Lab B's test will produce more false positives than Lab A's test.
4. The prevalence of the disease was higher in the population tested by Lab A.

Explanation: When you encounter genetic test validation questions, focus on the precise definitions of sensitivity, specificity, and error rates. These terms have exact mathematical relationships that don't change between labs. Sensitivity measures a test's ability to correctly identify positive cases, calculated as: $\text{Sensitivity} = \frac{\text{True Positives}}{\text{True Positives + False Negatives}}$. The false negative rate is simply 100% minus sensitivity. If Lab A has 92% sensitivity, its false negative rate is 8%. Lab B directly reports an 8% false negative rate, meaning its sensitivity is also 92%. Therefore, both tests have identical sensitivity, making answer A correct. Answer B is wrong because we have no information about specificity, which relates to false positive rates and true negatives—completely separate from the sensitivity data given. Answer C is incorrect for the same reason; false positive rates depend on specificity, not sensitivity. We cannot determine anything about false positives from the provided information. Answer D is flawed because disease prevalence in the tested populations doesn't affect the intrinsic performance characteristics of the tests themselves. Sensitivity and specificity are properties of the test, not the population. Study tip: Remember that sensitivity = 100% - false negative rate, and specificity = 100% - false positive rate. These are fixed test characteristics. Don't confuse them with prevalence, which describes the population being tested. On genetics exams, always identify which test performance metric is actually being discussed before drawing conclusions.

Question 19

1. A likely decrease in the test's specificity. (correct answer)
2. An increase in cost and complexity of the assay.
3. A necessary increase in the false negative rate.
4. A reduced ability to screen large populations efficiently.

Explanation: When you encounter questions about diagnostic test performance, focus on the fundamental relationship between sensitivity and specificity. These two measures are typically inversely related due to how diagnostic thresholds work. Sensitivity measures a test's ability to correctly identify positive cases (true positives), while specificity measures its ability to correctly identify negative cases (true negatives). To maximize sensitivity, you typically lower the threshold for calling a result "positive," which means you'll catch more true positive cases but also incorrectly classify more negative cases as positive. This trade-off means that as sensitivity increases, specificity generally decreases. Answer A is correct because this inverse relationship between sensitivity and specificity is a fundamental principle of diagnostic testing. When you make a test more sensitive, you inevitably reduce its specificity. Answer B is incorrect because increasing sensitivity doesn't necessarily require making the test more expensive or complex—it often just involves adjusting the interpretation threshold of existing results. Answer C represents a misunderstanding: maximizing sensitivity actually decreases false negatives (cases missed by the test), not increases them. Answer D is wrong because higher sensitivity doesn't inherently affect the scalability or efficiency of population screening—the same test can be applied to large populations regardless of its sensitivity setting. Remember this key principle: sensitivity and specificity exist in tension with each other. On genetics exams, when you see questions about optimizing one parameter of a diagnostic test, immediately consider what happens to the other parameter as a result of that optimization.

Question 20

1. 25
2. 475
3. 950 (correct answer)
4. 8550

Explanation: This is a multi-step problem. First, determine the number of people without the condition: 10,000 (total) - 500 (with condition) = 9,500. Specificity is the proportion of disease-free individuals who test negative. A specificity of 90% means the false positive rate is 100% - 90% = 10%. False positives occur in the disease-free group. Therefore, the number of false positives is 10% of 9,500, which is 0.10 * 9,500 = 950.